UB Paderborn / Katalog / Suche / in CDI

1 – 8 von 8

Sortiert nach

The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial

Therapeutic advances in urology, 2015-08, Vol.7 (4), p.167-179

2015

Link zum Volltext

Verfügbarkeit prüfen

The PRESIDE trial: A randomized, double-blind, placebo-controlled phase III efficacy and safety study of continued enzalutamide plus docetaxel after disease progression on enzalutamide alone in patients with metastatic castration-resistant prostate cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS5083-TPS5083

2015

Link zum Volltext

Verfügbarkeit prüfen

An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers

Clinical neuropharmacology, 2010-03, Vol.33 (2), p.55-60

2010

Link zum Volltext

Verfügbarkeit prüfen

Characterisation using microphysiometry of CRF receptor pharmacology

European journal of pharmacology, 1999-08, Vol.379 (2), p.229-235

1999

Link zum Volltext

Verfügbarkeit prüfen

Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment--Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial

BMJ (British Medical Journal), 2010-07, Vol.341 (7766), p.c3337-237

2010

Link zum Volltext

Verfügbarkeit prüfen

Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment- Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial

BMJ. British medical journal (International ed.), 2010-07, Vol.341 (7766), p.237

International edition, 2010

Link zum Volltext

Verfügbarkeit prüfen

P-47 Medication adherence amongst people with less than ideal glycaemic control — the lifestyle over and above drugs in diabetes (LOADD) study

Diabetes research and clinical practice, 2008, Vol.79, p.S72-S72

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 8 von 8

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(8)
Mit Volltextzugriff
(6)

Publikationsform

Artikel
(8)

Sprache

Englisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial

Next‐generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells

The PRESIDE trial: A randomized, double-blind, placebo-controlled phase III efficacy and safety study of continued enzalutamide plus docetaxel after disease progression on enzalutamide alone in patients with metastatic castration-resistant prostate cancer

An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers

Characterisation using microphysiometry of CRF receptor pharmacology

Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment--Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial

Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment- Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial

P-47 Medication adherence amongst people with less than ideal glycaemic control — the lifestyle over and above drugs in diabetes (LOADD) study

Suchergebnisse filtern